| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766-3773, 2015 | 461 | 2015 |
| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 214 | 2019 |
| Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium P Quaglino, M Maule, HM Prince, P Porcu, S Horwitz, M Duvic, R Talpur, ... Annals of Oncology 28 (10), 2517-2525, 2017 | 150 | 2017 |
| Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study P Quaglino, HM Prince, R Cowan, M Vermeer, E Papadavid, M Bagot, ... British Journal of Dermatology 184 (4), 722-730, 2021 | 65 | 2021 |
| Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center D Miyashiro, JA Sanches Scientific reports 10 (1), 9774, 2020 | 63 | 2020 |
| Ulcers in leprosy patients, an unrecognized clinical manifestation: a report of 8 cases D Miyashiro, C Cardona, NYS Valente, J Avancini, G Benard, ... BMC infectious diseases 19, 1-5, 2019 | 37 | 2019 |
| Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management D Miyashiro, JA Sanches Frontiers in oncology 13, 1141108, 2023 | 36 | 2023 |
| Cutaneous manifestations of adult T-cell leukemia/lymphoma D Miyashiro, JA Sanches Seminars in Diagnostic Pathology 37 (2), 81-91, 2020 | 35 | 2020 |
| Progression of mycosis fungoides after treatment with dupilumab: A case report. D Miyashiro, AG Vivarelli, F Gonçalves, J Cury‐Martins, JA Sanches Dermatologic therapy 33 (6), 2020 | 30 | 2020 |
| Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario JA Sanches, J Cury-Martins, RM Abreu, D Miyashiro, J Pereira Anais brasileiros de dermatologia 96 (4), 458-471, 2021 | 29 | 2021 |
| Chronic activation profile of circulating CD8+ T cells in Sézary syndrome MP Torrealba, KC Manfrere, DR Miyashiro, JF Lima, L de M Oliveira, ... Oncotarget 9 (3), 3497, 2017 | 27 | 2017 |
| Increasing awareness of human T-lymphotropic virus type-1 infection: a serious, invisible, and neglected health problem in Brazil M Puccioni-Sohler, MFR Grassi, B Galvão-Castro, A Caterino, ... Revista da Sociedade Brasileira de Medicina Tropical 52, e20190343, 2019 | 22 | 2019 |
| Paraneoplastic skin disorders: a review. D Miyashiro, JA Sanches Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa …, 2015 | 17 | 2015 |
| Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort D Miyashiro, JA Sanches International journal of dermatology 61 (4), 442-454, 2022 | 12 | 2022 |
| Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital WQGW Ceglio, MM Rebeis, MF Santana, D Miyashiro, J Cury-Martins, ... Anais brasileiros de dermatologia 97 (01), 14-21, 2022 | 12 | 2022 |
| Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome KCG Manfrere, MP Torrealba, DR Miyashiro, LMS Oliveira, ... Oncotarget 7 (46), 74592, 2016 | 12 | 2016 |
| The role of tumor microenvironment in the pathogenesis of Sézary syndrome D Miyashiro, BC Souza, MP Torrealba, KCG Manfrere, MN Sato, ... International Journal of Molecular Sciences 23 (2), 936, 2022 | 11 | 2022 |
| Cutaneous metastases from solid neoplasms-Literature review D Miyashiro, MS Pincelli, JA Sanches Anais brasileiros de dermatologia 98, 571-579, 2023 | 9 | 2023 |
| An update on Epstein-Barr virus–and human T-lymphotropic virus type-1–induced cutaneous manifestations. CME Part II AA Gru, JA Plaza, JA Sanches, D Miyashiro, OP Sangueza, FB Puccio, ... Journal of the American Academy of Dermatology 88 (5), 983-998, 2023 | 8 | 2023 |
| Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome KCG ManfrereC, MP Torrealba, DR Miyashiro, NZ Pereira, ... Oncotarget 8 (54), 92183, 2017 | 8 | 2017 |
